Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

被引：0
作者：
Lawal, Odunayo [1 ]
Lupak, Oleksandra [2 ]
Udo, Itoro [3 ]
Emole, Josephine [4 ]
机构：
[1] Univ Arizona, Clin & Translat Sci Program, Tucson, AZ USA
[2] Med Univ South Carolina, Hematol Oncol, Charleston, SC 29425 USA
[3] Western Univ, Dept Psychiat, London, ON, Canada
[4] Henry Ford Hosp, Stem Cell Transplantat & Cellular Therapy, Detroit, MI 48202 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CT; CAR-T therapy; neuropsychiatric disorders; multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-423
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapies for multiple myeloma
    Chao Wu
    Lina Zhang
    Qierra R. Brockman
    Fenghuang Zhan
    Lijuan Chen
    Journal of Hematology & Oncology, 12
  • [22] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
    Chen, Wei
    Wang, Ying
    Qi, Kunming
    Shi, Ming
    Cao, Jiang
    Bhansali, Rahul
    Wang, Xue
    Liu, Yang
    Li, Hujun
    Zhang, Huanxin
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
  • [23] Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma
    Mohan, Meera
    Chakraborty, Rajshekhar
    Bal, Susan
    Nellore, Anoma
    Baljevic, Muhamed
    D'Souza, Anita
    Pappas, Peter G.
    Berdeja, Jesus G.
    Callander, Natalie
    Costa, Luciano J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 736 - 746
  • [24] Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
    Ben Zadok, Osnat Itzhaki
    Simitsis, Panagiotis
    Jacobson, Caron
    Nadeem, Omar
    Frigault, Matthew J.
    Raje, Noopur
    Duffy, Caitlyn
    Costello, Patrick
    Dela Cruz, Jamie
    Looka, Andrew
    Nohria, Anju
    CIRCULATION, 2024, 150 (22) : 1815 - 1817
  • [25] Interventions and Outcomes of Multiple Myeloma Patients Progressing after BCMA-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Van Oekelen, Oliver
    Nath, Karthik
    Mouhieddine, Tarek H.
    Farzana, Tasmin
    Aleman, Adolfo
    Melnekoff, David T.
    Ghodke-Puranik, Yogita
    Jagannath, Sundar
    Shah, Urvi A.
    Mailankody, Sham
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S428 - S428
  • [26] Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
    Parikh, Rujul H.
    Lonial, Sagar
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (03) : 275 - 285
  • [27] Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
    Zhou, Dian
    Wang, Ying
    Cheng, Hai
    Zhu, Lili
    Chen, Wei
    Li, Hujun
    Zhang, Xiaotian
    Xia, Jieyun
    Qi, Yuekun
    Ma, Sha
    Zhu, Feng
    Yan, Zhiling
    Qi, Kunming
    Sang, Wei
    Sun, Haiying
    Li, Depeng
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 179 - 185
  • [28] Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia
    Emole, Josephine
    Lawal, Odunayo
    Lupak, Oleksandra
    Rangarajan, Hemalatha
    Udo, Itoro
    LEUKEMIA RESEARCH REPORTS, 2023, 19
  • [29] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
    Salem, Dalia A.
    Maric, Irina
    Yuan, Constance M.
    Liewehr, David J.
    Venzon, David J.
    Kochenderfer, James
    Stetler-Stevenson, Maryalice
    LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
  • [30] Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
    Timmers, Marijke
    Roex, Gils
    Wang, Yuedi
    Campillo-Davo, Diana
    Van Tendeloo, Viggo F., I
    Chu, Yiwei
    Berneman, Zwi N.
    Luo, Feifei
    Van Acker, Heleen H.
    Anguille, Sebastien
    FRONTIERS IN IMMUNOLOGY, 2019, 10
12345